Penumbra Inc PEN

Morningstar Rating
$321.69 +0.31 (0.10%)
View Full Chart

Company Report

Price vs Fair Value

PEN is trading at a LOCK|BkjRlH premium.
Price
$321.46
Fair Value
FC?
Uncertainty
LOCK|KH?
1-Star Price
LOCK|G.^Gt
5-Star Price
LOCK|>$
Economic Moat
LOCK|N&w
Capital Allocation
LOCK|f<lh#%

Bulls Say, Bears Say

Bulls

Penumbra’s computer-assisted vacuum thrombectomy, Lightning Flash, offers leading-edge technology that minimizes patient bleeding and whittles down procedure time.

Bears

Rival Stryker’s recent acquisition of Inari Medical means Penumbra will be going head-to-head with a formidable rival in peripheral thrombectomy.

News

Trading Information

Previous Close Price
$321.46
Day Range
$320.46–322.04
52-Week Range
$270.29–360.84
Bid/Ask
$321.67 / $321.85
Shares Outstanding
39.41M
Market Cap
$12.67B
Volume/Avg
50,327 / 352,144

Key Statistics

Price/Earnings (Normalized)
76.99
Price/Sales
8.15
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
4,700

Competitors

Valuation

Metric
PEN
BSX
SYK
Price/Earnings (Normalized)
76.9914.0122.71
Price/Book Value
8.002.535.26
Price/Sales
8.153.144.76
Price/Cash Flow
50.0113.1823.30
Price/Earnings
PEN
BSX
SYK

Financial Strength

Metric
PEN
BSX
SYK
Quick Ratio
3.720.621.07
Current Ratio
5.891.362.18
Interest Coverage
148.3210.679.73
Quick Ratio
PEN
BSX
SYK

Profitability

Metric
PEN
BSX
SYK
Return on Assets (Normalized)
10.94%10.68%11.66%
Return on Equity (Normalized)
14.05%19.06%24.04%
Return on Invested Capital (Normalized)
11.36%13.72%15.46%
Return on Assets
PEN
BSX
SYK

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|?$n@RMLOCK|@p!&y$191B
Medtronic PLC
MDT
LOCK|H^#&mwLOCK|!r&s?$130B
Stryker Corp
SYK
LOCK|k^Dw^PqLOCK|tV$123B
Boston Scientific Corp
BSX
LOCK|&z^Tzg?LOCK|h#!@l$65B
Edwards Lifesciences Corp
EW
LOCK|nQhxq@!!LOCK|RdfTN$60B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|%HScq?vLOCK|!@c$38B
DexCom Inc
DXCM
LOCK|c@J#%rnLOCK|>jj&$30B
Koninklijke Philips NV ADR
PHG
LOCK|Y!CLOCK|%<$30B
Steris PLC
STE
LOCK|N#%kQ^LOCK|vQ#!$25B
Zimmer Biomet Holdings Inc
ZBH
LOCK|^#Qn&%j#LOCK|<H$20B

Sponsor Center